Ainos Inc. (AIMD) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Ainos Inc. (AIMD:NASDAQ), powered by AI.

Current Price
$3.16
P/E Ratio
-0.9
Market Cap
13M
Sector
Healthcare
What is the Ainos Inc. stock price forecast?

Ainos Inc. is currently trading at $3.16. View real-time AI analysis on Alpha Lenz.

What is Ainos Inc. insider trading activity?

View the latest insider trading data for Ainos Inc. on Alpha Lenz.

What is Ainos Inc.'s P/E ratio?

Ainos Inc.'s P/E ratio is -0.9.

Ainos Inc.

NASDAQ · AIMD
$3.16+1.63(+106.54%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Ainos Inc.'s future dividend policy...
Alpha Chat Insight

Ainos Inc. trades at a P/E of -0.9 (undervalued) with modest ROE of -128.0%.

Ask for details

Company Overview

Ainos Inc. is a biotech and healthcare technology company primarily focused on the development and commercialization of innovative diagnostic and therapeutic solutions. Ainos offers a portfolio of products and services that address critical unmet medical needs, particularly in the areas of infectious diseases and chronic health conditions. The company's technological advancements include proprietary biosensor technologies and smart medical devices, which pave the way for more precise, rapid, and cost-effective health diagnostics. Ainos Inc.'s activities impact several sectors, such as healthcare, biotechnology, and medical devices, by introducing breakthrough approaches that enhance patient care and enable early disease detection. By doing so, the company contributes to the improvement of public health and the efficiency of healthcare systems. Operating in rapidly evolving markets, Ainos is strategically positioned to influence future trends in personalized medicine and connected health solutions. The firm's commitment to innovation and cutting-edge technology underscores its role in advancing healthcare diagnostics and therapeutics in a competitive global market.

CEOMr. Chun-Hsien Tsai
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees44

Company Statistics

FY 2025

Profile

$13.50MMarket Cap
$124.16KRevenue
0.00Shares Out
44Employees

Margins

82.89%Gross
-7472.92%EBITDA
-11268.32%Operating
-11896.40%Pre-Tax
-11897.04%Net

Valuation

-0.91P/E
1.78P/B
108.70EV/Sales
-2.60EV/EBITDA
-2.90P/FCF

Growth (CAGR)

-67.20%Rev 3Yr
49.61%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-59.45%ROA
-128.00%ROE
-56.58%ROIC

Financial Health

$417.35KCash & Cash Equivalents
$12.89MNet Debt
175.98%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Ainos Inc. (ticker: AIMD) is a company listed on NASDAQ in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 44 employees. Market cap is $13M.

The current price is $3.16 with a P/E ratio of -0.91x and P/B of 1.78x.

ROE is -128.00% and operating margin is -11268.32%. Annual revenue is $124,157.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Ainos Inc. (AIMD) Stock Forecast 2026 $3.16 — Price, Financials & Analyst Targets | Alpha Lenz